# Preoperative Semaglutide Prior to Radical Prostatectomy

> **NCT07727473** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Banner Health** · enrollment: 20 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Semaglutide 2.4 mg

## Key facts

- **NCT ID:** NCT07727473
- **Lead sponsor:** Banner Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-05
- **Final completion:** 2029-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07727473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07727473, "Preoperative Semaglutide Prior to Radical Prostatectomy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07727473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*